IQVIA, which happens to be a leading global provider of clinical research services, healthcare intelligence to the life sciences and healthcare industries, and also commercial insights, has gone on to unveil custom-built AI agents at GTC Paris.
The new custom-built AI agents of IQVIA that use NVIDIA technology are designed to elevate workflows as well as speed up the insights for life sciences. These live applications when it comes to agentic architecture go on to spill-out how IQVIA AI, as well as the deep domain expertise, are indeed transforming the business processes and along with it the patient results.
According to Bhavik Patel, who is the president of IQVIA commercial solutions, this is indeed an important opportunity in order to deliver accurate, efficient workflows as well as insights that are required by the modern life sciences sector, backed by deep industry expertise along with powerful technology collaborations. He added that their partnership with NVIDIA enables them to realize their vision so as to power smart healthcare for each and every one and that too everywhere.
It is well to be noted that while IQVIA Healthcare – grade AI has been delivering insights with accuracy, speed, as well as trust which are required for the life sciences sector throughout the asset life cycle. This recent partnership with NVIDIA happens to represent a very exciting new phase as they advance the powerful future that has been promised by agentic AI in a way that meets the distinct requirements of life sciences companies.
Making utmost use of NVIDIA NIM Agent Blueprints when it comes to rapid development, the NeMo Customizer in terms of fine-tuning, and Nemo Guardrails in order to safeguard rollout, IQVIA is developing agents that will help find breakthroughs and, at the same time, simplify the operations throughout the life sciences. Use cases for these agentic offerings, which go on to include target identification, literature review, clinical data review, market evaluation, and HCP engagement.
The vice president of healthcare at NVIDIA, Kimberly Powell, said that every moment counts when planning clinical trials, right from discovery to commercial application. While working with industry leaders such as IQVIA, one can build domain-specific agents that can demonstrate efficiency as well as accuracy. One instance is AI, which is helping researchers sift through the literature reviews by enabling IQVIA’s thousands of customers the potential to take advantages from their collaboration.
It is well to be noted that IQVIA announced a strategic collaboration with NVIDIA in January 2025 so as to build customized foundation models as well as agentic AI workflows in order to speed up the research, clinical development, and access to new treatments. The AI applications which happen to be trained on the massive healthcare-specific information of IQVIA are going to enable the industry to go ahead and also enhance, streamline as well as focus on the clinical trials along with the commercial launches with powerful workflow coordination in addition to the insights.
